Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

FDA Drug Recalls

11,818 recalls · Class II, newest first

Class II · Moderate risk

Mitomycin 0.02%

Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

Terminated Sterility / contamination Leiter's Compounding NDC 70360-005-35 D-0015-2017
Class II · Moderate risk

Marcaine 0.5%

Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.

Terminated Sterility / contamination Hospira Inc., A Pfizer Company NDC 0409-1610-50 D-0097-2017
Class II · Moderate risk

Marcaine 0.25%

Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.

Terminated Sterility / contamination Hospira Inc., A Pfizer Company NDC 0409-1587-50 D-0096-2017
Class II · Moderate risk

Desoximetasone Cream USP

Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).

Terminated Stability / shelf life Taro Pharmaceuticals, Inc. NDC 51672-1271-7 D-0117-2017
Class II · Moderate risk

Desoximetasone Cream USP

Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).

Terminated Stability / shelf life Taro Pharmaceuticals, Inc. NDC 51672-1270-7 D-0116-2017

Recalls by year